TARO News and Press, Taro Pharmaceutical Industries Ltd. From 06/10/19

The healthcare sector is underperforming the market by a wide margin on a year to date basis. The Healthcare Select Sector ETF ( XLV ) has gained 5.2%, while the SPDR S&P 500 ( SPY ) is up by almost three times that, with a cumulative gain of 15.1% in the same period. Data by YCharts ...

Taro Pharmaceutical Industries Ltd. (TARO) Q4 2019 Results Conference Call May 23, 2019 08:00 AM ET Company Participants William Coote - AVP, Business Finance, Treasurer and IR Dilip Shanghvi - Chairman Uday Baldota - CEO Mariano Balaguer - CFO Conference Call Participants ...

Taro Pharmaceutical (NYSE: TARO ): Q4 GAAP EPS of $1.52 misses by $0.74 . Revenue of $179.9M (+2.7% Y/Y) misses by $10M . Press Release More news on: Taro Pharmaceutical Industries Ltd., Earnings news and commentary, Healthcare stocks news,

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2019. Quarter ended March 31, 2019 Highlights ─ compared to March 31, 2018 Net sales of...

Earnings Call to Discuss Results to be Conducted Thursday, May 23 at 8:00 am ET Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for year ended March 31, 2019, on Wednesday, May 22, 2019. The Company will conduct an ea...

Taro Pharmaceutical (NYSE: TARO ): Q3 Non-GAAP EPS of $1.37 misses by $0.58 ; GAAP EPS of $2.40. Revenue of $176.4M (+13.5% Y/Y) beats by $1.7M . Press Release More news on: Taro Pharmaceutical Industries Ltd, Earnings news and commentary, Healthcare stocks news,

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and nine months ended December 31, 2018. Quarter ended December 31, 2018 Highlights ─ compared to December 31, 2017 ...

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended December 31, 2018, after the close of market on Wednesday, February 6, 2019. The release will be accessible on Taro’s website at www.taro.com . ...

Taro Pharmaceutical (NYSE: TARO ): Q1 EPS of $1.71 misses by $0.62 . More news on: Taro Pharmaceutical Industries Ltd, Earnings news and commentary, Healthcare stocks news, Read more ...

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2018. Quarter ended June 30, 2018 Highlights - compared to June 30, 2017 Net sales of $154.6 million, de...